Kezar Life Sciences Appoints Nick Mordwinkin as Chief Business Officer and Reports Updated Cash Position
“We are excited to welcome
“I am thrilled to join Kezar at such a pivotal time for the company as it continues to advance its pipeline of development candidates,” said
In addition, Kezar is reporting an unaudited cash position of approximately
About
View source version on businesswire.com: https://www.businesswire.com/news/home/20220711005095/en/
Investor Contact
Vice President, Investor Relations and External Affairs
650-269-7523
gjain@kezarbio.com
Media Contact
212-600-1902
kezar@argotpartners.com
Source: